Indications And Dose
Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with either a sulfonylurea or pioglitazone or insulin ▶BY MOUTH ▶Adult: 1 tablet twice daily
PDF page 756
Loading InternPractice…
Drug reference
Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with either a sulfonylurea or pioglitazone or insulin ▶BY MOUTH ▶Adult: 1 tablet twice daily
PDF page 756
Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (July 2008) that Janumet ® is accepted for restricted use within NHS Scotland for the treatment of type 2 diabetes mellitus when the addition of a sulfonylurea to metformin is not appropriate; it is also accepted for use in NHS Scotland in combination with a sulfonylurea in patients inadequately controlled on maximum tolerated doses of metformin and a sulfonylurea.
PDF page 756
→Appendix 1: metformin. sitagliptin
PDF page 756
There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 21 ▶Janumet (Merck Sharp & Dohme Ltd) Sitagliptin (as Sitagliptin phosphate) 50 mg, Metformin hydrochloride 1 gram Janumet 50mg/1000mg tablets | 56 tablet P £33.26 DT = £33.26
PDF page 756
1 tablet twice daily
First-line fragment. Read the complete Indications and Dose section above.
PDF page 756